Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DHR vs MRNA✓SelectedUSD · MRNADHR vs MRNA performance historyLatest closeAs of-3.16%11/20
Stock and ETF performance explorer

DHR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-18.7%
MRNA return
-27.3%
Excess return
+8.5%
Maximum drawdown
-43.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.2%-2.2%-1.0%-3.0%
7D-5.4%-12.7%+7.3%-4.4%
30D-5.8%-20.7%+14.9%-4.3%
3M+2.2%+46.3%-44.0%-1.4%
6M+29.3%+305.2%-276.0%+4.2%
YTD-3.2%+561.2%-564.4%-29.2%
1Y-0.1%+772.1%-772.2%-30.6%
3Y+6.3%+147.0%-140.7%-15.9%
All-18.7%-27.3%+8.5%-26.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling